Pre-Exam Preparation For Medicine (January 1, 2014) - (935152549X)
Pre-Exam Preparation For Medicine (January 1, 2014) - (935152549X)
Pre-Exam Preparation For Medicine (January 1, 2014) - (935152549X)
for
Medicine
Pre-exam Preparation
for
Medicine
HN Sarker
edicated to
My parents, wife and children
Preface
Acknowledgments
Contents
3974
7598
Chapter 4 Hepatology
99126
CHAPTER
1
Cardiovascular System
Malignancy
Tuberculosis
Pulmonary infarction.
ii. Chest wall disorders:
Rib fracture/injury
Intercostal muscle injury
Costochondritis (Tietzes syndrome)
Epidemic myalgia (Bornholm disease).
iii. PsychogenicAnxiety.
iv. Musculoskeletal:
Herpes zoster
Herniated intervertebral disk.
Characteristics
Angina
Myocardial infarction
Duration
Precipitated
Relieved by
Rest, nitrates
Sympathetic
None
activity
Nausea or
vomiting
Unusual
Cardiovascular System
Site
Central, diffuse
Peripheral, localized
Character
Tight, squeezing,
choking
Sharp, stabbing,
catching
Radiation
Jaw/neck/shoulder/arm No radiation/other
Precipitation
By exertion/emotion
By posture, respiration
or movement/palpation
Relieving
Rest, nitrate
factors
Associated
Breathlessness
features
Respiratory, GI or
locomotors
Esophageal pain
Precipitated
By exertion
Relieved
Rapidly relieved by rest, Not rapidly relieved by
nitrates
rest; often relieved by
nitrates
Wakes patient
Rare
from sleep
Often
Relation to
heartburn
No
Sometimes
Duration
Upto10 min
Variable
Cardiovascular System
Q.16.
Ans.
Q.17.
Cardiovascular System
Cardiovascular System
10
Cardiovascular System
Q.54.
Ans.
11
12
Q.57.
Ans.
Q.58.
Ans.
Reperfusion therapy:
If primary PCI available, give GP IIb/IIIa inhibitor
then PCI.
Alternatively give thrombolysis.
Cardiovascular System
Arrhythmia
Ischemia
Cardiogenic shock.
13
14
Q.69.
Ans.
Cardiovascular System
15
16
Cardiovascular System
Q.83.
Ans.
17
18
Cardiovascular System
19
20
Cardiovascular System
21
Multiple ectopics
Atrial flutter with variable block.
22
Cardiovascular System
23
24
Cardiovascular System
i. Congenital
ii. Acquired
Idiopathic fibrosis
MI/ischemia
Inflammation
AcuteAortic root abscess in infective endocarditis
ChronicSarcoidosis and Chagas disease.
Cardiac surgery
DrugsDigoxin and b-blocker.
Nausea
Light-headedness
Palpitation
Chest pain
Light-headedness
Sweating
Extreme 'death-like'
pallor
Pallor
Often none
Recovery
Unconscious
period
Premonitory
symptoms
Neurocardiogenic
syncope (vasovagal
syncope)
Cardiac syncope
25
Seizures
Often none
Confusion
Cardiac syncope
Hyperexcitability
Olfactory hallucinations
'Aura'
Chest pain
Breathlessness
Unconscious period Extreme 'death-like' Prolonged (> 1 min)
pallor
unconsciousness
Motor seizure activity
Tongue-biting
Urinary incontinence
Recovery
Rapid recovery
Prolonged confusion
(< 1 min)
(> 5 min)
Flushing
Headache
Focal neurological signs
Light-headedness
Palpitation
Premonitory
symptoms
26
Cardiovascular System
DBP
mmHg
or
160
or
140159
and
or
Stage 2
Hypertension
<120
120139
<80
8089
9099
Stage 1
Hypertension
Normal
Prehypertension
SBP
mmHg
BP
classification
100
27
28
Cardiovascular System
Recommendation
Weight reduction
Modification
Dietary sodium
reduction
Physical activity
Moderation of alcohol
Q.148.
Ans.
29
30
Q.150.
Ans.
Cardiovascular System
31
32
Cardiovascular System
Arthralgia
Previous rheumatic fever
Raised ESR or CRP
Leukocytosis
First-degree AV block.
33
34
Cardiovascular System
Q.176.
Ans.
35
36
Q.181.
Ans.
Q.182.
Ans.
Q.183.
Ans.
Q.184.
Ans.
Cardiovascular System
37
38
CHAPTER
2
Respiratory System
40
Respiratory System
Lung abscess
COPD (infective exacerbation)
Cystic fibrosis.
Q.11.
Ans.
41
42
Respiratory System
Transudative
43
44
Respiratory System
Q.33.
Ans.
Q.34.
Ans.
Restrictive
FEV1
VC
or Normal
FEV1/VC
Normal or
Test
45
46
Respiratory System
47
Feature
Diagnosis Clinical
Pathological
Appearance
Blue bloater
Pink puffer
Prominent
Absent
Cyanosis
Chronic bronchitis
Emphysema
Hyperinflation +
++
Dyspnea
++
Cough
++
++
Cor pulmonale
Q.51.
Ans.
48
Q.55.
Ans.
Respiratory System
49
50
Stage Severity
I
Mild
II
Moderate
III
Severe
IV
Very severe
FEV1
FEV1/FVC < 0.70
FEV180% predicted
FEV1/FVC < 0.70
50% FEV1 < 80% predicted
FEV1/FVC < 0.70
30% FEV1 < 50% predicted
FEV1/FVC < 0.70
FEV1 < 30% predicted or FEV1 < 50%
predicted plus chronic respiratory failure
Respiratory System
Q.70.
Ans.
51
52
Polycythemia
Pneumothorax
Secondary infection.
Respiratory System
53
54
Respiratory System
Simultaneously, begin a slow deep inspiration, depress
the canister and continue to inhale. Hold the breath for
10 seconds.
Q.88.
Ans.
Q.89.
Ans.
Q.92.
Ans.
55
56
Respiratory System
Pulmonary tuberculosis
Pneumonia complicating measles and whooping
cough
Suppurative pneumonia
Inhaled foreign body
CongenitalKartagener's syndrome, cystic fibrosis,
and primary hypogammaglobulinemia.
57
58
Q.108.
Ans.
Q.109.
Ans.
Respiratory System
59
60
Respiratory System
61
62
Respiratory System
Smear negative
Symptoms suggestive of tuberculosis with 3
negative sputum specimens
Persisting symptoms after a course of antibiotics
3 negative sputum specimen or repeated X-ray
negative.
c. According to treatment category
Category 1
Category 2.
63
64
Respiratory System
Cardiac muscle
Skeletal muscle
Thyroid gland
Pancreas.
65
66
Respiratory System
Treatment regimen
Patient category
Intensive
phase
(Daily)
TB diagnostic
category
Continuation
phase
(Daily)
4(HR)
Contd...
67
Patient category
TB diagnostic
category
Pretreatment
weight (Kg)
>70
3037
3854
5570
Category II:
Continuation phase
Daily (Next 5 months)
Intensive phase
Daily
Daily
(First 3
(First 2
months)
months)
Number of Injection
4FDC
streptomtablets
ycin
500 mg
3037
Number of
2FDC
tablets
Pretreatment
weight (Kg)
Intensive phase
Continuation phase
Daily (First 2 months)
Daily (Next 4 months)
Number of 4FDC tablets Number of 2FDC tablets
2
2
3
3
4
4
II
Continuation
phase
(Daily)
Intensive
phase
(Daily)
Contd...
68
Ethambutol
400 mg
(Number of
tablets)
2
Contd...
Respiratory System
Continuation phase
Daily (Next 5 months)
Intensive phase
Daily
Daily
(First 3
(First 2
months)
months)
Number of Injection
4FDC
streptomtablets
ycin
1 gm*
1 gm*
Ethambutol
400 mg
(Number of
tablets)
700 mg
>70
5570
3854
Number of
2FDC
tablets
Pretreatment
weight (Kg)
Contd...
Q.164. Name a single side effect from each of the 1st line antiTB drugs?
Ans.
Rifampicin Hepatitis
INHPeripheral neuropathy
PyrazinamideHepatitis/ Hyperuricemia (gouty arthritis)
EthambutolOptic neuritis
StreptomycinOtotoxicity (8th cranial nerve palsy)
ThiacetazoneSteven-Johnsons syndrome.
69
70
Treatment response
By 2nd weekSputum smear becomes negative
After 4 weeksFeeling well, weight gain, no fever, no
cough and sputum
By 2 months80% culture negative
By 3 months100% culture negative
Chest radiograph Should have improved.
Respiratory System
Active immunization
ChemoprophylaxisINH 5 mg/kg/day for 9 months.
Q.172.
Ans.
71
72
Neurological
Polyneuropathy.
Myelopathy.
Cerebellar degeneration.
Myasthenia (Lambert-Eaton syndrome).
Others
Digital clubbing.
Hypertrophic pulmonary osteoarthropathy.
Nephrotic syndrome.
Polymyositis and dermatomyositis.
Eosinophilia.
Respiratory System
Q.182. A young male presents with sudden severe rightsided chest pain and breathlessness. On examination,
resonant on percussion and absent breath sound on
right side. What is your diagnosis?
Ans. Right-sided pneumothorax is the diagnosis.
Q.183.
Ans.
Q.184.
Ans.
What is pneumothorax?
Pneumothorax is the presence of air in the pleural space.
73
74
Examination
Lobar pneumonia
Pneumothorax
Trachea
Central
Deviated to opposite
site
Hyper-resonant
auscultation
Bronchial breath sound
vocal resonance
or absent breath
sound
or absent vocal
resonance
CHAPTER
3
Gastrointestinal System
76
Peptic stricture
Fibrous ring
Malignant
Carcinoma of esophagus
Carcinoma of stomach
Extrensic compression
Esophagitis
Peptic esophagitis
Candidiasis
DysmotilityAchalasia.
Oropharyngeal dysphagia
Esophageal dysphagia
Gastrointestinal System
symptom that includes epigastric pain, heartburn,
distension, nausea or 'an acid feeling' occurring after
eating or drinking.
Hematemesis Hemoptysis
Vomiting of blood
Coughing up blood
Acidic reaction
Alkaline in reaction
77
78
Q.18.
Ans.
Q.19.
Ans.
Gastrointestinal System
Q.24.
Ans.
Q.25.
Ans.
Q.26.
Ans.
Q.27.
Ans.
Q.28.
Ans.
Q.29.
Ans.
Q.30.
Ans.
79
80
Gastrointestinal System
81
82
Gastrointestinal System
83
84
Fat
Fluid (ascites)
Feces
Flatus
Fetus.
Gastrointestinal System
85
86
Gastrointestinal System
Q.65.
Ans.
87
88
Gastrointestinal System
89
90
Gastrointestinal System
Q.85.
Ans.
91
92
Gastrointestinal System
IBS
Types of disease
Functional bowel
disorder
Ulcer in the GIT
No
Predominant clinical Altered bowel habit
features
and abdominal pain
Complications
Less
Treatment
Reassurance, medical
and psychotherapy
Q.97.
Ans.
IBD
Inflammatory
Yes
Blood diarrhea
More
Prompt medical
and surgical
treatment
93
94
Gastrointestinal System
Ulcerative colitis
Crohn's disease
95
96
Gastrointestinal System
Q.115.
Ans.
Q.116.
Ans.
97
98
Behet's syndrome.
Neoplasia
Carcinoma
Leukemia
Kaposi's sarcoma.
CHAPTER
4
Hepatology
Halothane
Isoniazid
Rifampicin
Allopurinol
Amitriptylin
Azathioprin
Indomethacin
Ibuprofen
Amiodarone.
Hepatology
101
Hepatology
ii.
iii.
iv.
v.
vi.
103
Q.25. Why?
Ans. It is more common in developing countries and spread
by feco-oral route.
Q.28. Why?
Ans. In developing countries, by this age person becomes
immune to hepatitis A due to clinical or subclinical
infection.
Hepatology
105
iii.
iv.
Hepatology
107
Hepatology
Cryptogenic (unknown-15%)
Chronic venous outflow obstruction
3. Clinical classification:
Compensated cirrhosis: Cirrhosis without any
evidence of decompensation.
Decompensated cirrhosis: As evidenced by ascites,
increasing jaundice and encephalopathy.
109
portal
and
failure
Hepatology
Q.58.
Ans.
Q.59.
Ans.
Q.60.
Ans.
Q.61.
Ans.
Q.62.
Ans.
Purpura, ecchymosis
Generalized pigmentation
Hepatic facies
Gynecomastia in male and breast atrophy in female
Loss of hair.
111
Q.65.
Ans.
Hepatology
Q.71.
Ans.
Q.72.
Ans.
113
Hepatology
Q.81.
Ans.
115
Hypokalemia
Infection
Trauma/surgery
Portosystemic shunts.
Clinical
grade
Clinical signs
slow
Grade 2
Grade 3
Grade 4
Q.86.
Ans.
Hepatology
117
Bilirubin (mol/L)
Albumin (gm/L)
Prothrombin time (seconds prolonged)
Ascites.
Survival (%)
5 years
10 years
45 25
20 7
20 0
Hepatology
Variceal bleeding
Ascites
Formation of collaterals like caput medusa
Fetor hepaticus: Results from portosystemic shunting
of blood which allows mercaptans to pass directly to
lungs.
Extracellular
volume replacement
To stop bleeding
119
Q.103.
Ans.
Hepatology
121
Budd-Chairi syndrome
Leptospirosis
4. Cryptogenic: (non A-E hepatitis).
Hyperacute
< 7 days
Hepatology
Secondary
Multiple nodules
Bruit present
Rub present
Umbilication absent
Umbilication present
CEA normal
CEA increased
123
Hepatology
tinidazole), followed by luminal cysticide: Diloxanide
furoate 500 mg 8 hourly for 10 days.
125
Pyogenic
Amebic
History
Organism
E.coli
Entamoeba histolytica
Various streptococci
(Streptococcus milleri)
Anaerobes
Bacteroides
Age
Onset
Old age/immune
compromised
Acute
Not so
Investigation
Treatment
Ampicillin gentamicin
and metronidazole
(AGM) duration of
treatment is more
Metronidazole
Diloxanide furoate
Duration of treatment
is less
More fatal
Less fatal
Clinical
features
Prognosis
Insidious
CHAPTER
5
Hematology
Hematology
Headache
Paresthesia.
Common signs
Pallor
Peripheral edema
Cardiac dilatation.
129
Hematology
Q.31.
Ans.
Q.32.
Ans.
131
Hematology
133
Hematology
135
Normal hemoglobins
Types
Structure
Adult
Hb A
a2 b2
Hb A2
22
Hb F
22
Fetal
Hematology
137
Q.67. What are the indications of splenectomy
thalassemia?
Ans. Indications of splenectomy in thalassemia are:
Features of hypersplenism
Significant mechanical pressure
Increased frequency of blood transfusion
Splenic rupture.
in
Hematology
139
ix. Hypokalemia
x. Citrate toxicity
xi. DIC.
Late:
i. Hemosiderosis
ii. Hemochromatosis.
Q.79.
Ans.
Hematology
2.
Restrictive cardiomyopathy: Iron overload leading
to hemosiderosis and finally hemochromatosis
and develops restrictive cardiomyopathy.
ii. Intercurrent infection.
141
Meningococcal septicemia
DrugsAspirin, NSAIDs
Aplastic anemia
Acute leukemia.
Chronic
Occurs in children
Occurs in adults
Acute onset
Insidious onset
Self-limiting
Chronic course
Commonly follows
respiratory infection
No history of respiratory
infection
Hematology
143
tooth
Hematology
with increased numbers of white cells in the bone
marrow and/or peripheral blood.
Q.109.
Ans.
145
Erythropoiesis Depressed
Megakaryopoiesis reduced.
Q.113.
Ans.
Hematology
147
Hematology
Q.130.
Ans.
Hodgkins
Non-Hodgkins
lymphoma lymphoma
Lymph node
involvement
Usually localized to
single axial group
Peripheral lymph
node involvement
Commonly involved
Lymph node
spread
Orderly spread by
contiguity
Noncontiguous
spread
Extranodal
involvement
Less common
More common
Systemic features
Common
Less common
Pel-Ebstein fever
May occur
Pruritis
Common
Less common
Histology
Reed-Sternberg cell
Absent
Prognosis
149
Hematology
151
CHAPTER
6
Renal System
Renal System
153
Q.13.
Ans.
Renal System
persistent or recurrent infection results in serious kidney
damage.
155
Q.25.
Ans.
Q.26.
Ans.
Renal System
Q.33.
Ans.
157
Q.36.
Which glomerulopathies present as nephrotic
syndrome?
Ans. Glomerulopathies present as nephrotic syndrome are:
Minimal change nephropathy
Focal segmental glomerulosclerosis (FSGS)
Membranous nephropathy
Diabetic nephropathy
SLE.
Q.37. Which glomerulopathies present as nephritonephrotic
syndrome?
Ans. Glomerulopathies present as nephitonephrotic syndrome are:
Mesangiocapillary glomerulonephritis
SLE
IgA nephropathy.
Q.38.
Ans.
Renal System
159
Renal System
161
Q.60.
Ans.
Q.61.
Ans.
Weight
Maintain fluid intake output chart
Albumin chart.
Renal System
163
Q.71.
Ans.
Q.72.
Ans.
Renal System
mg/m2
Q.74.
Ans.
165
Renal System
AGN
Nephrotic syndrome
Age
26 years usually
History: Pharyngitis
or skin infection
Clinical features:
Hematuria
Scratch mark
Hypertension
Present
Absent
Present
May be present
Present
Absent
Absent
May be present
High color
Mild to moderate
Present
Absent
Normal
Massive
Absent
Present
Urine examination
Color
Protein
RBC and RBC cast
Granular cast
Serum C3 level
Low
Relapse
Uncommon
Treatment
Mainly supportive
Normal
Common
Specific by
prednisolone
167
Risk
Injury
Failure
Loss
ESKD
GFR criteria
UO criteria
SCr 1.5 UO
SCr 2 UO
SCr 3 or SCr
> 350 mol/L with
an acute rise
> 40 mol/L
Renal System
GFR
(mL/min/1.73 m2)
1
Kidney damage with normal
90
or GFR
2
6089
Moderate GFR
3059
Severe GFR
1529
Kidney failure
169
Renal System
171
Renal System
173
Renal System
ii. Secondary (irritative) symptoms are urinary frequency, urgency of micturition and urge incontinence.
175
CHAPTER
7
Diabetes Mellitus
Diabetes Mellitus
Features
Type I
Type II
Age of onset
<30 years
>30 years
Body habitus
Normal to wasted
Obese/overweight
Insulin reserve
Low/absent
Normal/high
Acute complication
DKA
HONK
Insulin therapy
Responsive
Responsive
Symptom
Sudden, classical
Gradual, atypical
177
Sampling.
Plasma glucose is measured before and 2 hours after a
75 gm oral glucose drink.
Diabetes Mellitus
Dietary constituent
Carbohydrate
4560%
Sucrose
Upto 10%
Fat (total)
< 35%
n6 polyunsaturated
< 10%
n3 polyunsaturated
Monounsaturated 1020%
Saturated
Protein
Fruit/vegetables
< 10%
1015% (do not exceed 1 gm/kg body
weight)
5 portions daily
179
Diabetes Mellitus
Onset(hr) Duration(hr)
< 0.5
34.5
0.51
48
Intermediate-acting (isophane
(NPH), lente)
13
714
24
1230
12
1824
181
Q.27.
Can you demonstrate how to inject insulin
subcutaneously?
Ans. Steps to inject insulin subcutaneously are:
Needle sited at right angle to the skin.
Subcutaneous (not intramuscular) injection.
Delivery devices: Glass syringe (requires resterilization), plastic syringe (disposable), pen device, infusion pump.
Q.28.
Ans.
Q.29.
Ans.
Diabetes Mellitus
183
Hypoglycemic coma
DKA
History
No food
Vigorous exercise
Insulin overdose
Little or no insulin
Infection
Onset
Diabetes Mellitus
Contd...
Traits
Hypoglycemic coma
DKA
Signs
Smell of acetone
Common in elderly
Little or no breathless
Acetone breath
No smell of acetone
Q.43.
Ans.
185
Q.44.
Ans.
Q.45.
Ans.
Diabetes Mellitus
Diabetic Hypertensive
retinopathy
retinopathy
Present
Arteriovenous nipping
Absent
Present in grade 2
Hemorrhages
Flame-shaped
Exudates
Soft
Hard
Papilledema
Absent
Present in grade 4
Neovascularization
Present in proli-
Absent
ferative retinopathy
187
CHAPTER
8
Endocrine System
Hyperactive
Hypoactive
Pituitary
Acromegaly
Dwarfism
Thyroid
Thyrotoxicosis
Hypothyroidism
Parathyroid
Hyperparathyroidism Hypoparathyroidism
Cushing's syndrome
Adrenal
Addison's disease
Weight gain
myxedematous
Weight loss
Lean and thin
TSH raised
TSH low
Biochemically
Endocrine System
191
T4 T3
Undetectable
Raised
Primary thyrotoxicosis
Undetectable
Normal Raised
Undetectable
Elevated > 20
mU/L
Low
Low
Primary hypothyroidism
Undetectable/
normal
Low
Low
Secondary hypothyroidism
Primary hypothyroidism
Secondary hypothyroidism
Mildly elevated
520 mU/L
Raised
Primary T3-toxicosis
Elevated
Raised Raised
Noncompliance with T4
replacement-recent
'loading' dose
Secondary thyrotoxicosis
Endocrine System
193
Q.35.
Ans.
causes
of
transient
Endocrine System
195
Endocrine System
Q.55.
Ans.
197
Endocrine System
iii. Ophthalmopathy
Management:
a. Cessation of smoking
b. Artificial tear drop
c. Oral prednisolone if severe inflammation
d. Urgent surgical decompression if visual acuity loss.
iv. Dermopathy (pretibial myxedema)
Management: Local steroids.
199
Endocrine System
201
Endocrine System
Q.87.
Ans.
203
Endocrine System
Diabetes insipidus
Diabetes mellitus
Etiology
Deficiency of or
unresponsive to ADH
Absolute or relative
deficiency of insulin
Hyperglycemia
Absent
Present
Glycosuria
Absent
Present
Plasma osmolality
Low
Normal or high
Urine osmolality
Low
High
Low
High
205
CHAPTER
9
Musculoskeletal Disease
Musculoskeletal Disease
Viral arthritis
Systemic lupus erythematosus (SLE)
Generalized osteoarthritis
Juvenile idiopathic arthritis.
207
Score
Joint involvement
Serology
1
2
3
5
2
3
Acute-phase
Normal CRP and normal ESR
reactants
Duration of
symptoms
<6 weeks
6 weeks
Musculoskeletal Disease
iii. Z deformity of the thumb (hyperextension of the interphalangeal joint and fixed flexion and subluxation
of metacarpophalangeal joint of the thumb).
iv. Triggering of fingers.
v. Ulnar deviation of hands.
vi. Dorsal subluxation of the ulna at the distal radioulnar
joint.
vii. Radial deviation of wrist.
Foot joint
Hammer toe deformity
Knee joint
It may develop varus/valgus deformity.
Q.13.
Ans.
Q.14.
Ans.
Q.15.
Ans.
Q.16.
Ans.
209
Peripheral neuropathy
Mononeuritis multiplex.
Musculoskeletal Disease
211
Musculoskeletal Disease
213
Musculoskeletal Disease
Anakinra
Rituximab
Abatacept
Tocilizumab.
215
Renal disorder
Serositis
Arthritis
Oral ulcers
Photosensitivity
Discoid rash
Malar rash
Features
Contd...
Musculoskeletal Disease
Characteristics
Neurological
disorder
Features
Hematological
disorder
Immunological
disorder
Contd...
217
Musculoskeletal Disease
219
Musculoskeletal Disease
Achilles tendenitis
Anterior uveitis
Aortic incompetence
Cardiac conduction defects
Pulmonary apical fibrosis.
Q.78. What are the modified New York criteria (1984) for
diagnosis for ankylosing spondylitis?
Ans. Modified New York criteria (1984) for diagnosis consist
of the following:
1. History of inflammatory back pain
2. Limitation of motion of the lumbar spine in both the
sagittal and frontal planes
3. Limited chest expansion
4. Definite radiographic sacroiliitis.
Criterion 4 plus any one of the other three criteria is sufficient for a diagnosis of definite AS.
221
Ankylosing spondylitis
RA
Onset2nd3rd decade
More in male
More in female
Sacroiliitis, spondylitis,
asymmetrical oligoarthritis
involving large joints
Uveitis
Scleritis
Musculoskeletal Disease
Q.86.
Ans.
223
Q.92.
Ans.
Keratoderma blennorrhagica
Nail dystrophy
Oral ulcer
Uveitis.
Musculoskeletal Disease
Mechanical
arthritis
Inflammatory
arthritis
Any age
Below 40 years
Onset
Age
Acute
Insidious
Family history
Absent
Usually positive
Morning stiffness
Absent
Present
Better
Worse
Rest
Contd...
225
Mechanical
arthritis
Inflammatory
arthritis
Activity
Worse
Improved
Signs of
Absent
inflammation
Q.103.
Ans.
Present
Musculoskeletal Disease
227
CHAPTER
10
Nervous System
Clinical signs
Power
Weak
Upper limbs: extensors
weaker
Lower limbs: flexors
weaker
Weak
Wasting
None
Yes
Fasciculation
None
Yes
Tone
Spastic increase
Reflexes
Increased
Reduced/ absent
Flexor
Nervous System
229
Q.12.
Ans.
Q.13.
Ans.
Nervous System
Contralateral lower-half of
face is involved
231
Pseudobulbar palsy
Bulbar palsy
Lesion of corticobulbar
pathways to V,VII,X,XI,XII
Bilateral UMN
LMN lesion
Spastic dysarthria
Nervous System
Referred headache
Headache of raised intracranial pressure.
233
Nervous System
state for half an hour or more after regaining
consciousness. Full memory function may not be
recovered for some hours. After a generalized seizure
the patient usually feels terrible, may have a headache
and will want to sleep.
Q.41.
Ans.
Seizure
Syncope
Present
Absent
Cyanosis
Present
Absent
Tongue biting
Present
Absent
Postictal confusion
Present
Absent
Postictal amnesia
Present
Absent
Postictal headache
Present
Absent
Rapid recovery
No
Yes
Aura(e.g. olfactory)
Traits
Age
Young age
Sex
More in females
Any age
Both sexes are equally
affected
Contd...
235
Traits
True convulsion
Convulsion
Pseudoconvulsion
Duration
Short duration
Present
Eyeball
Rolling
Fixed
Postictal
confusion,
headache,
amnesia
Absent
Present
Nervous System
237
Meningitis
Encephalitis.
ii. Metabolic/endocrine
Hypoxia (respiratory failure)
Hyper-/hypoglycemia
Hyponatremia
Liver failure and renal failure.
iii. Vascular
Acute cerebral hemorrhage/infarction
Subarachnoid hemorrhage.
iv. Toxic
Alcohol intoxication/withdrawal
Drugs (therapeutic/illicit).
iv. Neoplastic
Secondary deposits.
v. Trauma
Head injury (cerebral contusions)
Subdural hematoma.
Nervous System
B12 deficiency
Hypothyroidism.
239
Nervous System
241
Nervous System
i. AntiplateletAspirin
ii. Control of risk factors
iii. For carotid TIA, carotid Doppler studyIf significant
stenosis (>70% stenosis), carotid angiogram, and
endarterectomy.
243
Q.78.
Ans.
Nervous System
245
Q.94.
Ans.
Nervous System
Neuropathy
Myopathy
Sensory symptom
May be present
Absent
Pattern of weakness
Predominately
distal
Predominately
proximal
Wasting
May be severe
Tone
Absent
Plantar
May be extensor
Flexor
Co-ordination
May be lost
Intact
Sensory function
Impaired
Intact
247
CSF Normal
Pressure
50250 mm of water
Color
Clear
04 all lymphocytes
Glucose
Protein
Microbiology
Sterile
Normal
Appearance
Clear
Cells /L
Protein(gm/L) Normal
Glucose
Normal
Microbiology
Nervous System
Common
i. Neonate
Pressure
Appearance
Cloudy/turbid
10005000 polymorphs
Cells /L
Protein(gm/L) Increased
Glucose
Reduced
Microbiology
Organism Antibiotic
Unknown
pyogenic
Cefotaxime
Benzylpenicillin
Meningococcus
Pneumococcus Cefotaxime
Haemophilus Cefotaxime
249
Pressure
Appearance
Clear/ cloudy
Cells /L
Protein(gm/L) Increased
Glucose
Reduced
Microbiology
Tuberculous meningitis
Appearance
Cloudy/ turbid
Clear/ cloudy
Cells /L
Nervous System
Contd...
Tuberculous meningitis
Glucose
Markedly reduced
Reduced
Ziehl-Neelsen stain +
culture AFB
Microbiology
251
Thyrotoxic tremor
Parkinsons tremor
Action tremor
Rest tremor
bilateral
unilateral
Diminished at rest
Diminished on action
Q.125.
Ans.
Nervous System
253
CHAPTER
11
Skin
Skin
255
Trauma
Infection
Sunlight
DrugsAntimalarials, -blockers, ACE inhibitors and
lithium
Emotion and anxiety.
Ill-defined margin
Central healing
No central healing
Skin
257
Skin
Acquired Congenital
Early
Primary
Clinical and latent
Secondary
Latent
Late
Latent
Clinical and latent
Benign tertiary
Cardiovascular
Neurosyphilis
259
Character
Primary chancre
Chancroid
Ulcer
A single painless
indurated ulcer
CHAPTER
12
Infectious Diseases
Fever
Headache
Myalgia
Relative bradycardia
Constipation
Diarrhea and vomiting in children.
Infectious Diseases
2nd week
Stool culture
Blood culture
Urine culture
Widal test.
Q.15.
Ans.
263
Infectious Diseases
265
Infectious Diseases
267
Infectious Diseases
Q.53.
Ans.
269
Infectious Diseases
Q.63.
Ans.
271
Q.70.
Ans.
Q.73.
Ans.
Dapsone
100 mg
6 months
Multibacillary
(>5 skin lesions)
Clofazimine
50 mg
Dapsone
100 mg
12 months
Rifampicin
600mg
Clofazimine
300 mg
Contd...
Infectious Diseases
Contd...
Types of leprosy Monthly
Daily self-
Duration
supervised
administered
of treatment
drug treatment drug treatment
Paucibacillary
single-lesion
leprosy (one
skin lesion)
Ofloxacin
400 mg
Rifampicin
600 mg
Minocycline
100 mg
Single dose
Traits
Amebic dysentery
Bacillary dysentery
Number of motion
Amount
Odor
Color
Nature
68/day
Copious
Offensive
Dark red
Blood and mucus
mixed with feces
Over 10 times
Small
Odorless
Bright red
Blood and mucus
no feces
Tennismus
Absent
Present
273
Infectious Diseases
275
Infectious Diseases
Hepatitis
Encephalitis
Encephalomyelitis
Subacute sclerosing panencephalitis (SSP).
Q.97.
Ans.
277
CHAPTER
13
Poisoning
Poisoning
Emesis
Lacrimation
Salivation
Bradycardia
ii. Nicotinic
Muscle twiching
Cramp
Fasciculation
Weakness of respiratory muscle.
iii. CNS
Confusion
Slurring of speech
Headache
Convulsion
Coma.
279
Poisoning
Dyspnea
Chemical pneumonitis.
Q.11.
Ans.
281
CHAPTER
14
Psychiatry
Somatization disorder
Dissociative (conversion) disorder
Pain disorder
Hypochondriasis
Body dysmorphic disorder
Somatoform autonomic dysfunction.
Neurasthenia
Puerperal mental disorder.
Psychiatry
Groups Drugs
Phenothiazine
Chlorpromazine
Butyrophenone
Haloperidol
Thioxanthenes
Flupenthixol decanoate
Diphenylbutylpiperidine
Pimozide
Substituted benzamides
Sulpiride
Dibenzodiazepines
Clozapine
Benzisoxazole
Risperidone
Thienobenzodiazepines
Olanzapine
Dibenzothiazepines
Quetiapine
Q.10.
Ans.
285
Dry mouth
Blurred vision
Constipation
Urinary retention.
Q.13.
Ans.
Psychiatry
Antianxiety
Sodium valproate
Lamotrigine
Benzodiazepines
b-adrenoceptor antagonists.
287
Unipolar depression
Bipolar disorder
Dysthymia.
Q.25.
Ans.
Psychiatry
289
Adjustment disorder
Posttraumatic stress disorder.
Q.34.
Ans.
CHAPTER
15
Obesity
BMI Classifications
< 18.5
18.524.9
Underweight
Normal weight
25.029.9
Overweight
30.034.9
Class I obesity
35.039.9
Class II obesity
40.0
CHAPTER
16
Genetics
CHAPTER
18
Immunity
Examples
Anaphylaxis
II
III
Serum sickness
IV
Montoux test
CHAPTER
19
Environment
Environment
It is not a fever
Hyperpyrexia
Hyperpyrexia is a fever
301
CHAPTER
20
Deficiency symptoms
Vitamin A
Vitamins
Nutrition
Vitamin K
Vitamin E
Vitamin D
Night blindness
Xerophthalmia
Bitot's spots
Keratomalacia
Blindness
Nutrition
Beriberi
i. Dry (or neurological) beriberiChronic peripheral
neuropathy and with wrist and/or foot drop.
Korsakoff's psychosis Wernicke's encephalopathy.
ii. Wet (or cardiac) beriberiGeneralized edema
due to biventricular heart failure with pulmonary
congestion.
303
Nutrition
Marasmus
Iodine deficiency
Night blindness due to vitamin A deficiency
Iron deficiency anemia.
305
CHAPTER
21
Electrolytes
Electrolytes
307
Electrolytes
309